Valuation Alterity Therapeutics Limited

Stocks

Market Closed - Australian S.E. Other stock markets 10:10:15 03/07/2026 +04			5-day change	1st Jan Change
0.6700 ^AUD	+3.08%		+19.64%	+67.50%

06-09	Alterity Therapeutics Achieves Alignment With U.S. FDA On Pivotal Phase 3 Program For ATH434 In Multiple System Atrophy	CI
06-03	Alterity Therapeutics Limited Announces Change of Registered Office Address	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	43.75	21.56	11.37	14	59.84	98.01	-	-
Change	-	-50.72%	-47.27%	23.14%	327.48%	63.79%	-	-
Enterprise Value (EV) ¹	43.75	21.56	11.37	9.172	38.2	52.82	57.13	60.91
Change	-	-50.72%	-47.27%	-19.31%	316.5%	38.27%	8.15%	6.61%
P/E	-	-	-	-	-	-0.38x	-0.38x	-0.38x
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-0.65x	-1.96x
Capitalization / Revenue	13.3x	6.11x	4.45x	4.81x	11.3x	38.2x	81.7x	41.1x
EV / Revenue	13.3x	6.11x	4.45x	3.15x	7.24x	20.6x	47.6x	25.6x
EV / EBITDA	-	-	-	-0.71x	-4.68x	-3.38x	-2.51x	-2.62x
EV / EBIT	-4.07x	-2.07x	-1.22x	-0.71x	-4.87x	-3.15x	-1.81x	-1.72x
EV / FCF	-	-2.53x	-	-1.07x	-5.11x	-5.05x	-2.63x	-2.85x
FCF Yield	-	-39.6%	-	-93.4%	-19.6%	-19.8%	-38.1%	-35.1%
Dividend per Share ³	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ³	-	-	-	-	-	-1.707	-1.717	-1.72
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3.292	3.528	2.554	2.909	5.278	2.568	1.2	2.383
EBITDA ¹	-	-	-	-12.95	-8.155	-15.64	-22.74	-23.26
EBIT ¹	-10.75	-10.42	-9.321	-12.97	-7.839	-16.79	-31.53	-35.49
Net income ¹	-11.19	-8.843	-8.966	-12.97	-7.927	-14.62	-29.6	-33.19
Net Debt ¹	-	-	-	-4.826	-21.64	-45.19	-40.88	-37.1
Reference price ³	1.4000	0.6500	0.3500	0.2000	0.5000	0.6500	0.6500	0.6500
Nbr of stocks (in thousands)	41,680	48,137	48,798	104,902	182,547	217,508	-	-
Announcement Date	31/08/21	31/08/22	31/08/23	29/08/24	28/08/25	-	-	-

¹AUD in Million²USD in Million³AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALTERITY THERAPEUTICS LIMITED	-0.38x	20.57x	-3.38x	-	98.01M
LONZA GROUP AG	34.02x	5.98x	18.5x	0.96%	49.15B
REVOLUTION MEDICINES, INC.	-23.69x	348.44x	-22.41x	-.--%	40.23B
IQVIA HOLDINGS INC.	25.19x	2.79x	12.06x	-.--%	34.55B
BEONE MEDICINES AG	44.97x	4.49x	28.67x	-.--%	33.09B
CELLTRION, INC.	29.73x	7.68x	19.76x	0.42%	25.19B
MEDPACE HOLDINGS, INC.	32.72x	5.32x	24.23x	-.--%	15.92B
EUROFINS SCIENTIFIC SE	24.01x	2.04x	8.98x	1.11%	13.83B
ICON PUBLIC LIMITED COMPANY	24.5x	1.94x	11.76x	-.--%	13.26B
Average	21.23x	44.36x	10.91x	0.31%	25.04B
Weighted average by Cap.	22.21x	66.09x	11.26x	0.33%